Total Payments
$3,713
2024 Payments
$172.60
Companies
20
Transactions
189
Payment Breakdown by Category
Food & Beverage$3,554 (95.7%)
Education$158.62 (4.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,554 | 181 | 95.7% |
| Education | $158.62 | 8 | 4.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $1,021 | 41 | $0 (2024) |
| Allergan, Inc. | $735.99 | 36 | $0 (2020) |
| ABBVIE INC. | $664.20 | 42 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $202.92 | 12 | $0 (2021) |
| Lundbeck LLC | $186.83 | 12 | $0 (2019) |
| Abbott Laboratories | $154.19 | 1 | $0 (2019) |
| ITI, Inc. | $136.92 | 8 | $0 (2023) |
| Shire North American Group Inc | $121.97 | 7 | $0 (2019) |
| Neos Therapeutics, LP | $107.74 | 7 | $0 (2021) |
| Avanir Pharmaceuticals, Inc. | $74.91 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $172.60 | 12 | ABBVIE INC. ($138.69) |
| 2023 | $357.05 | 19 | AbbVie Inc. ($212.22) |
| 2022 | $205.51 | 11 | ABBVIE INC. ($148.82) |
| 2021 | $372.56 | 24 | AbbVie Inc. ($164.47) |
| 2020 | $239.83 | 20 | Allergan, Inc. ($115.24) |
| 2019 | $651.09 | 27 | Otsuka America Pharmaceutical, Inc. ($256.71) |
| 2018 | $943.25 | 46 | Otsuka America Pharmaceutical, Inc. ($480.89) |
| 2017 | $770.76 | 30 | Allergan Inc. ($315.47) |
All Payment Transactions
189 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.49 | General |
| Category: NEUROSCIENCE | ||||||
| 08/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.45 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: PSYCHIATRY | ||||||
| 07/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.28 | General |
| Category: NEUROSCIENCE | ||||||
| 06/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: NEUROSCIENCE | ||||||
| 04/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Education | In-kind items and services | $8.45 | General |
| Category: NEUROSCIENCE | ||||||
| 03/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: NEUROSCIENCE | ||||||
| 03/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Education | In-kind items and services | $8.45 | General |
| Category: NEUROSCIENCE | ||||||
| 02/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.02 | General |
| Category: NEUROSCIENCE | ||||||
| 01/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: PSYCHIATRY | ||||||
| 12/14/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: NEUROSCIENCE | ||||||
| 11/29/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2023 | AbbVie Inc. | VRAYLAR (Drug) | Education | In-kind items and services | $8.45 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.16 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: PSYCHIATRY | ||||||
| 07/19/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: PSYCHIATRY | ||||||
| 07/14/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: NEUROSCIENCE | ||||||
| 07/08/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.22 | General |
| Category: NEUROSCIENCE | ||||||
| 05/13/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.87 | General |
| Category: PSYCHIATRY | ||||||
| 05/08/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: NEUROSCIENCE | ||||||
| 05/04/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: INSOMNIA | ||||||
About Dr. Mary Ty, M.D
Dr. Mary Ty, M.D is a Specialist healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/28/2008. The National Provider Identifier (NPI) number assigned to this provider is 1003085507.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mary Ty, M.D has received a total of $3,713 in payments from pharmaceutical and medical device companies, with $172.60 received in 2024. These payments were reported across 189 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($3,554).
Ad
Practice Information
- Specialty Specialist
- Location Houston, TX
- Active Since 02/28/2008
- Last Updated 02/28/2008
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1003085507
Products in Payments
- VRAYLAR (Drug) $1,175
- REXULTI (Drug) $1,156
- VYVANSE (Drug) $176.58
- CRM-Research only (Device) $154.19
- Trintellix (Drug) $153.80
- CAPLYTA (Drug) $151.78
- NAMENDA XR (Drug) $143.45
- Adzenys XR-ODT (Drug) $120.19
- NUEDEXTA (Drug) $74.91
- VIIBRYD (Drug) $53.92
- TRINTELLIX (Drug) $51.22
- MYDAYIS (Drug) $39.28
- QUVIVIQ (Drug) $36.36
- HETLIOZ (Drug) $36.26
- Otovel (Drug) $35.95
- SILENOR (Drug) $31.79
- UBRELVY (Drug) $28.26
- SUNOSI (Drug) $24.80
- Fanapt (Drug) $23.20
- SPRAVATO (Drug) $16.54
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Houston
Daniel Tung, M.d, M.D
Specialist — Payments: $1.0M
Specialist $1.0M
Dr. James Welsh, Md, MD
Specialist — Payments: $432,652
Specialist $432,652
Dr. Amin Jamal, M.d.,P.a, M.D.,P.A
Specialist — Payments: $264,808
Specialist $264,808
Dr. Rosa Tang, M.d, M.D
Specialist — Payments: $248,234
Specialist $248,234
Dr. Stephen Mahoney, M.d, M.D
Specialist — Payments: $191,264
Specialist $191,264
Dr. Fiaz Zaman, M.d, M.D
Specialist — Payments: $172,386
Specialist $172,386